# Innventure, Inc.: overview

INV · Nasdaq · CIK 2001557 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inv.md) · [Financials](/companies/inv/financials.md) · [Filings](/companies/inv/filings.md) · [Insiders](/companies/inv/insiders.md)

Latest reported revenue: [$953.0k](/filings/0002001557-26-000154.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0002001557-26-000154).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.3](/filings/0001628280-25-052035.md) | [0.5](/filings/0002001557-26-000060.md) | [0.2](/filings/0002001557-26-000115.md) | [0.5](/filings/0002001557-26-000154.md) | [0.5](/filings/0001628280-25-052035.md) | [0.8 d](/filings/0002001557-26-000060.md) | [1.4](/filings/0002001557-26-000115.md) | [1.0](/filings/0002001557-26-000154.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(4313.6%)](/filings/0001628280-25-052035.md) | [(8837.1%)](/filings/0002001557-26-000060.md) | [(116606.3%)](/filings/0002001557-26-000115.md) | [(29952.5%)](/filings/0002001557-26-000154.md) | [(5469.1%)](/filings/0001628280-25-052035.md) | [(3859.1%) d](/filings/0002001557-26-000060.md) | [(1891.7%)](/filings/0002001557-26-000115.md) | [(3304.1%)](/filings/0002001557-26-000154.md) |
| Net margin | % | [(697.5%)](/filings/0001628280-25-052035.md) | [(13542.5%)](/filings/0002001557-26-000060.md) | [(63837.9%)](/filings/0002001557-26-000115.md) | [(17694.7%)](/filings/0002001557-26-000154.md) | [(5305.6%)](/filings/0001628280-25-052035.md) | [(4593.8%) d](/filings/0002001557-26-000060.md) | [(1441.8%)](/filings/0002001557-26-000115.md) | [(2781.0%)](/filings/0002001557-26-000154.md) |
| Diluted EPS | $ per share | [(0.94)](/filings/0001628280-25-052035.md) | [(1.41)](/filings/0002001557-26-000060.md) | [(3.10)](/filings/0002001557-26-000115.md) | [(1.60)](/filings/0002001557-26-000154.md) | [(0.51)](/filings/0001628280-25-052035.md) | not reported | [(0.27)](/filings/0002001557-26-000115.md) | [(0.32)](/filings/0002001557-26-000154.md) |
| Free cash flow | $m | [(2.3) d](/filings/0001628280-25-052035.md) | [(29.5)](/filings/0002001557-26-000060.md) | [(15.6)](/filings/0002001557-26-000115.md) | [(22.1) d](/filings/0002001557-26-000154.md) | [(20.0) d](/filings/0001628280-25-052035.md) | [(24.4) d](/filings/0002001557-26-000060.md) | [(34.9)](/filings/0002001557-26-000115.md) | [(25.7) d](/filings/0002001557-26-000154.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 6-month figure less the 3-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001628280-25-017614.md) | [2.1](/filings/0002001557-26-000060.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | [(2119.8%)](/filings/0001628280-25-017614.md) | [(22602.1%)](/filings/0002001557-26-000060.md) |
| Net margin | % | [(2761.4%)](/filings/0001628280-25-017614.md) | [(14266.4%)](/filings/0002001557-26-000060.md) |
| Diluted EPS | $ per share | not reported | [(5.39)](/filings/0002001557-26-000060.md) |
| Free cash flow | $m | [(20.1)](/filings/0001628280-25-017614.md) | [(82.1)](/filings/0002001557-26-000060.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/inv/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.0m | 3,754,254 |  | Added +649,793 |
| [PNC Financial Services Group, Inc.](/funds/713676.md) | 2026-06-30 | $17.3m | 3,419,063 |  | Added +344,733 |
| [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $15.1m | 2,987,465 |  | New +2,987,465 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.2m | 2,807,557 |  | Added +228,964 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $14.0m | 2,756,695 |  | Added +2,297,737 |
| [Abundance Wealth Counselors](/funds/1767080.md) | 2026-06-30 | $7.9m | 1,566,239 |  | Added +783,348 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.1m | 1,398,342 |  | Added +191,120 |
| [STIFEL FINANCIAL CORP](/funds/720672.md) | 2026-06-30 | $6.1m | 1,193,954 |  | Added +344,861 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.9m | 1,172,280 |  | Added +202,155 |
| [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $5.8m | 1,141,441 |  | Reduced −117,117 |

## Recent filings

[All 350 filings](/companies/inv/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:30 ET | [8-K](/filings/0002001557-26-000198.md) | 3.01 Delisting notice | 0002001557-26-000198 |
| 2026-10-20 | 06:55 ET | [SCHEDULE 13D/A](/filings/0002041777-26-000006.md) | Ownership report, active investor, amended | 0002041777-26-000006 |
| 2026-10-19 | 20:49 ET | [SCHEDULE 13D/A](/filings/0002041777-26-000005.md) | Ownership report, active investor, amended | 0002041777-26-000005 |
| 2026-10-20 | 17:31 ET | [8-K](/filings/0002001557-26-000196.md) | 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0002001557-26-000196 |
| 2026-10-13 | 07:40 ET | [8-K](/filings/0002001557-26-000194.md) | 8.01 Other events | 0002001557-26-000194 |
| 2026-10-08 | 08:21 ET | [8-K](/filings/0002001557-26-000192.md) | 8.01 Other events | 0002001557-26-000192 |
| 2026-10-06 | 17:29 ET | [8-K](/filings/0001140361-26-038822.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038822 |
| 2026-10-05 | 16:25 ET | [8-K/A](/filings/0002001557-26-000190.md) | 5.02 Departure or appointment of officers or directors | 0002001557-26-000190 |
| 2026-09-21 | 08:17 ET | [8-K](/filings/0002001557-26-000175.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0002001557-26-000175 |
| 2026-09-15 | 09:01 ET | [8-K](/filings/0002001557-26-000171.md) | 8.01 Other events | 0002001557-26-000171 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002001557-26-000060.md), filed Mar 30, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ce7b734a-7051-4201-87f7-022cbcc4bdbe)

## About the filer

- CIK: 2001557
- Tickers: INV, INVLW
- Exchange: Nasdaq
- SIC code: 6770 Blank Checks
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 12:31 ET. No prices; not investment advice.